Over-the-counter carrageenan-based sprays may interfere with PCR testing of nasopharyngeal swabs to detect SARS-CoV-2
Taylor Corocher, Kira Edwards, Yvonne Hersusianto, Donald Campbell, Hui Yin Lim, Paul Monagle, Prahlad Ho
PLOS ONE, doi:10.1371/journal.pone.0316700
Carrageenan-containing nasal sprays, available over-the-counter (OTC), are often marketed as having anti-viral effects. Carrageenan belongs to the glycosaminoglycan family alongside heparin, and heparin is known to inhibit real-time quantitative polymerase chain reaction (RT-qPCR) in nasopharyngeal swabs used to detect SARS-CoV-2. As heparin and carrageenan share structural similarities, this work aimed to investigate the interferent effect of carrageenan on RT-qPCR for SARS-CoV-2 detection across 4 different diagnostic platforms. This work demonstrated that in the presence of carrageenan samples return inaccurate and invalid results on the Seegene STARlet, while qualitative accuracy was maintained on the Cepheid GeneXpert, Roche Cobas LIAT, and Hologic Panther Aptima. Evidence of carrageenan interference on SARS-CoV-2 testing was consistent across two OTC brands and research-grade reconstituted iota-carrageenan, with 80% of results returning invalid regardless of the carrageenan formulation added to the samples. Further, a preliminary in vivo interference study demonstrated an increased Ct value within 15 minutes of carrageenan dosage, with Ct values restored 60 minutes post-application. A direct comparison of carrageenan-and heparin-mediated PCR interference demonstrated that carrageenan PCR interference occurs to a lesser degree, but is not reversible by the addition of heparinase I. As carrageenan is available OTC, interference with PCR testing that causes an increase in false negative results could lead to accidental spread of disease and could therefore have significant public health impacts on community testing of respiratory infectious diseases via PCR.
Supporting information
S1 Table. 95% Confidence intervals (CI) for the CT values of the E-gene from samples presented in Formal analysis: Taylor Corocher, Kira Edwards. Funding acquisition: Donald Campbell, Paul Monagle. Investigation: Taylor Corocher, Kira Edwards.
Methodology: Taylor Corocher, Kira Edwards. Project administration: Kira Edwards. Resources: Hui Yin Lim. Supervision: Yvonne Hersusianto, Donald Campbell, Hui Yin Lim, Paul Monagle, Prahlad Ho. Validation: Taylor Corocher. Visualization: Taylor Corocher, Kira Edwards. Writing -original draft: Taylor Corocher, Kira Edwards.
Writing -review & editing: Taylor Corocher, Kira Edwards, Yvonne Hersusianto, Donald Campbell, Paul Monagle, Prahlad Ho.
References
Bovard, Van Der Toorn, Schlage, Constant, Renggli et al., Iota-carrageenan extracted from red algae is a potent inhibitor of SARS-CoV-2 infection in reconstituted human airway epithelia, Biochem Biophys Rep,
doi:10.1016/j.bbrep.2021.101187
Eccles, Meier, Jawad, Weinmüllner, Grassauer et al., Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold, Respir Res,
doi:10.1186/1465-9921-11-108
Eccles, Winther, Johnston, Robinson, Trampisch et al., Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the ICICC trial,
doi:10.1186/s12931-015-0281-8
Edwards, Corocher, Hersusianto, Campbell, Subbarao et al., Heparin-mediated PCR interference in SARS-CoV-2 assays and subsequent reversal with heparinase I, J Virol Methods,
doi:10.1016/j.jviromet.2024.114944
Fazekas, Eickhoff, Pruckner, Vollnhofer, Fischmeister et al., Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common cold, BMC Complement Altern Med,
doi:10.1186/1472-6882-12-147
Fröba, Große, Setz, Rauch, Auth et al., Iota-carrageenan inhibits replication of SARS-CoV-2 and the respective variants of concern Alpha, Beta, Gamma and Delta, Int J Mol Sci,
doi:10.3390/ijms222413202
Hugerth, Sundelöf, Effect of polyelectrolyte counterion specificity on dextran sulfate-amphiphile interaction in water and aqueous/organic solvent mixtures, Langmuir,
doi:10.1021/la9916880
Laurie, El-Zein, Franco, Coutlée, Assessment of the possible inhibitory effect of carrageenan in human papillomavirus DNA testing by polymerase chain reaction amplification, J Med Virol,
doi:10.1002/jmv.26963
Laurienzo, Marine polysaccharides in pharmaceutical applications: an overview, Mar Drugs,
doi:10.3390/md8092435
Ludwig, Enzenhofer, Schneider, Rauch, Bodenteich et al., Efficacy of a carrageenan nasal spray in patients with common cold: a randomized controlled trial, Respir Res,
doi:10.1186/1465-9921-14-124
Mahomoodally, Lobine, Rengasamy, Gowrishankar, Tewari et al., Marine algae: a potential resource of Anti-HSV molecules,
doi:10.3390/pr7120887
Shi, Wang, Lu, Qin, Hu et al., Overview on the antiviral activities and mechanisms of marine polysaccharides from seaweeds, Carbohydrate Res,
doi:10.1016/j.carres.2017.10.020
Weiss, Esko, Tor, Biomol, Author, Targeting heparin and heparan sulfate protein interactions, Org Biomol Chem,
doi:10.1039/c7ob01058c
DOI record:
{
"DOI": "10.1371/journal.pone.0316700",
"ISSN": [
"1932-6203"
],
"URL": "http://dx.doi.org/10.1371/journal.pone.0316700",
"abstract": "<jats:p>Carrageenan-containing nasal sprays, available over-the-counter (OTC), are often marketed as having anti-viral effects. Carrageenan belongs to the glycosaminoglycan family alongside heparin, and heparin is known to inhibit real-time quantitative polymerase chain reaction (RT-qPCR) in nasopharyngeal swabs used to detect SARS-CoV-2. As heparin and carrageenan share structural similarities, this work aimed to investigate the interferent effect of carrageenan on RT-qPCR for SARS-CoV-2 detection across 4 different diagnostic platforms. This work demonstrated that in the presence of carrageenan samples return inaccurate and invalid results on the Seegene STARlet, while qualitative accuracy was maintained on the Cepheid GeneXpert, Roche Cobas LIAT, and Hologic Panther Aptima. Evidence of carrageenan interference on SARS-CoV-2 testing was consistent across two OTC brands and research-grade reconstituted iota-carrageenan, with 80% of results returning invalid regardless of the carrageenan formulation added to the samples. Further, a preliminary <jats:italic>in vivo</jats:italic> interference study demonstrated an increased Ct value within 15 minutes of carrageenan dosage, with Ct values restored 60 minutes post-application. A direct comparison of carrageenan- and heparin-mediated PCR interference demonstrated that carrageenan PCR interference occurs to a lesser degree, but is not reversible by the addition of heparinase I. As carrageenan is available OTC, interference with PCR testing that causes an increase in false negative results could lead to accidental spread of disease and could therefore have significant public health impacts on community testing of respiratory infectious diseases via PCR.</jats:p>",
"author": [
{
"ORCID": "https://orcid.org/0000-0003-1127-0500",
"affiliation": [],
"authenticated-orcid": true,
"family": "Corocher",
"given": "Taylor",
"sequence": "first"
},
{
"ORCID": "https://orcid.org/0000-0002-8169-5187",
"affiliation": [],
"authenticated-orcid": true,
"family": "Edwards",
"given": "Kira",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Hersusianto",
"given": "Yvonne",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Campbell",
"given": "Donald",
"sequence": "additional"
},
{
"ORCID": "https://orcid.org/0000-0003-2455-3155",
"affiliation": [],
"authenticated-orcid": true,
"family": "Lim",
"given": "Hui Yin",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Monagle",
"given": "Paul",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Ho",
"given": "Prahlad",
"sequence": "additional"
}
],
"container-title": "PLOS ONE",
"container-title-short": "PLoS ONE",
"content-domain": {
"crossmark-restriction": false,
"domain": [
"www.plosone.org"
]
},
"created": {
"date-parts": [
[
2025,
2,
6
]
],
"date-time": "2025-02-06T18:59:02Z",
"timestamp": 1738868342000
},
"deposited": {
"date-parts": [
[
2025,
2,
6
]
],
"date-time": "2025-02-06T18:59:16Z",
"timestamp": 1738868356000
},
"editor": [
{
"affiliation": [],
"family": "Lin",
"given": "Shih-Chao",
"sequence": "first"
}
],
"funder": [
{
"name": "Victorian Government Department of Jobs, Skills, Industry and Regions"
},
{
"name": "Victorian Government Department of Jobs, Skills, Industry and Regions"
}
],
"indexed": {
"date-parts": [
[
2025,
2,
6
]
],
"date-time": "2025-02-06T19:40:06Z",
"timestamp": 1738870806610,
"version": "3.37.0"
},
"is-referenced-by-count": 0,
"issue": "2",
"issued": {
"date-parts": [
[
2025,
2,
6
]
]
},
"journal-issue": {
"issue": "2",
"published-online": {
"date-parts": [
[
2025,
2,
6
]
]
}
},
"language": "en",
"license": [
{
"URL": "http://creativecommons.org/licenses/by/4.0/",
"content-version": "vor",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2025,
2,
6
]
],
"date-time": "2025-02-06T00:00:00Z",
"timestamp": 1738800000000
}
}
],
"link": [
{
"URL": "https://dx.plos.org/10.1371/journal.pone.0316700",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "340",
"original-title": [],
"page": "e0316700",
"prefix": "10.1371",
"published": {
"date-parts": [
[
2025,
2,
6
]
]
},
"published-online": {
"date-parts": [
[
2025,
2,
6
]
]
},
"publisher": "Public Library of Science (PLoS)",
"reference": [
{
"DOI": "10.1016/j.jviromet.2024.114944",
"article-title": "Heparin-mediated PCR interference in SARS-CoV-2 assays and subsequent reversal with heparinase I",
"author": "K Edwards",
"doi-asserted-by": "crossref",
"first-page": "114944",
"journal-title": "J Virol Methods",
"key": "pone.0316700.ref001",
"volume": "327",
"year": "2024"
},
{
"DOI": "10.17221/6758-VETMED",
"article-title": "Carrageenan: a review",
"author": "J Necas",
"doi-asserted-by": "crossref",
"first-page": "187",
"issue": "4",
"journal-title": "Vet Med",
"key": "pone.0316700.ref002",
"volume": "58",
"year": "2013"
},
{
"key": "pone.0316700.ref003",
"unstructured": "Carrageenan market size and share analysis report; 2030. [cited 2024 Feb 1]. Available from: https://www.grandviewresearch.com/industry-analysis/carrageenan-market"
},
{
"DOI": "10.1002/jmv.26963",
"article-title": "Assessment of the possible inhibitory effect of carrageenan in human papillomavirus DNA testing by polymerase chain reaction amplification",
"author": "C Laurie",
"doi-asserted-by": "crossref",
"first-page": "6408",
"issue": "11",
"journal-title": "J Med Virol",
"key": "pone.0316700.ref004",
"volume": "93",
"year": "2021"
},
{
"DOI": "10.3390/pr7120887",
"article-title": "Marine algae: a potential resource of Anti-HSV molecules",
"author": "MF Mahomoodally",
"doi-asserted-by": "crossref",
"first-page": "887",
"issue": "12",
"journal-title": "Processes",
"key": "pone.0316700.ref005",
"volume": "7",
"year": "2019"
},
{
"DOI": "10.1016/B978-0-12-800269-8.00007-5",
"article-title": "Biological activities of carrageenan",
"author": "R Pangestuti",
"doi-asserted-by": "crossref",
"first-page": "113",
"journal-title": "Adv Food Nutr Res",
"key": "pone.0316700.ref006",
"volume": "72",
"year": "2014"
},
{
"DOI": "10.1016/j.carres.2017.10.020",
"article-title": "Overview on the antiviral activities and mechanisms of marine polysaccharides from seaweeds",
"author": "Q Shi",
"doi-asserted-by": "crossref",
"first-page": "1",
"journal-title": "Carbohydrate Res",
"key": "pone.0316700.ref007",
"year": "2017"
},
{
"DOI": "10.3390/md8092435",
"article-title": "Marine polysaccharides in pharmaceutical applications: an overview",
"author": "P Laurienzo",
"doi-asserted-by": "crossref",
"first-page": "2435",
"issue": "9",
"journal-title": "Mar Drugs",
"key": "pone.0316700.ref008",
"volume": "8",
"year": "2010"
},
{
"DOI": "10.1186/1465-9921-11-108",
"article-title": "Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold",
"author": "R Eccles",
"doi-asserted-by": "crossref",
"first-page": "108",
"issue": "1",
"journal-title": "Respir Res",
"key": "pone.0316700.ref009",
"volume": "11",
"year": "2010"
},
{
"article-title": "Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the ICICC trial",
"author": "R Eccles",
"key": "pone.0316700.ref010",
"year": "2012"
},
{
"DOI": "10.1186/1472-6882-12-147",
"article-title": "Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common cold",
"author": "T Fazekas",
"doi-asserted-by": "crossref",
"first-page": "1",
"journal-title": "BMC Complement Altern Med",
"key": "pone.0316700.ref011",
"volume": "12",
"year": "2012"
},
{
"DOI": "10.1186/1465-9921-14-124",
"article-title": "Efficacy of a carrageenan nasal spray in patients with common cold: a randomized controlled trial",
"author": "M Ludwig",
"doi-asserted-by": "crossref",
"first-page": "1",
"issue": "1",
"journal-title": "Respir Res",
"key": "pone.0316700.ref012",
"volume": "14",
"year": "2013"
},
{
"article-title": "Iota-carrageenan extracted from red algae is a potent inhibitor of SARS-CoV-2 infection in reconstituted human airway epithelia",
"author": "D Bovard",
"first-page": "101187",
"journal-title": "Biochem Biophys Rep",
"key": "pone.0316700.ref013",
"volume": "29",
"year": "2022"
},
{
"DOI": "10.3390/ijms222413202",
"article-title": "Iota-carrageenan inhibits replication of SARS-CoV-2 and the respective variants of concern Alpha, Beta, Gamma and Delta",
"author": "M Fröba",
"doi-asserted-by": "crossref",
"first-page": "13202",
"issue": "24",
"journal-title": "Int J Mol Sci",
"key": "pone.0316700.ref014",
"volume": "22",
"year": "2021"
},
{
"DOI": "10.1039/C7OB01058C",
"article-title": "Targeting heparin and heparan sulfate protein interactions",
"author": "RJ Weiss",
"doi-asserted-by": "crossref",
"first-page": "5656",
"issue": "27",
"journal-title": "Org Biomol Chem",
"key": "pone.0316700.ref015",
"volume": "15",
"year": "2017"
},
{
"DOI": "10.1021/la9916880",
"article-title": "Effect of polyelectrolyte counterion specificity on dextran sulfate−amphiphile interaction in water and aqueous/organic solvent mixtures",
"author": "A Hugerth",
"doi-asserted-by": "crossref",
"first-page": "4940",
"issue": "11",
"journal-title": "Langmuir",
"key": "pone.0316700.ref016",
"volume": "16",
"year": "2000"
}
],
"reference-count": 16,
"references-count": 16,
"relation": {},
"resource": {
"primary": {
"URL": "https://dx.plos.org/10.1371/journal.pone.0316700"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [],
"subtitle": [],
"title": "Over-the-counter carrageenan-based sprays may interfere with PCR testing of nasopharyngeal swabs to detect SARS-CoV-2",
"type": "journal-article",
"update-policy": "https://doi.org/10.1371/journal.pone.corrections_policy",
"volume": "20"
}